{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:04:15Z","timestamp":1780477455589,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,3]]},"DOI":"10.7759\/cureus.110163","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:15:34Z","timestamp":1780474534000},"source":"Crossref","is-referenced-by-count":0,"title":["Pharmacovigilance Analysis of Bleeding Events Associated With Selective Serotonin Reuptake Inhibitors (SSRIs) Using the US Food and Drug Administration Adverse Event Reporting System (FAERS)"],"prefix":"10.7759","author":[{"given":"Adrian Chin Yan","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani A","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al.. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018, 391:1357-66. 10.1016\/S0140-6736(17)32802-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001396.pub4","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder","volume":"8","author":"Jespersen C","year":"2024","unstructured":"Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database Syst Rev. 2024, 8:CD001396. 10.1002\/14651858.CD001396.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1060028018794005","article-title":"Clinical management of bleeding risk with antidepressants","volume":"53","author":"Bixby AL","year":"2019","unstructured":"Bixby AL, VandenBerg A, Bostwick JR. Clinical management of bleeding risk with antidepressants. Ann Pharmacother. 2019, 53:186-94. 10.1177\/1060028018794005","journal-title":"Ann Pharmacother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2025.102970","article-title":"Serotonin transporter deficiency, but not absence of platelet serotonin, impairs thrombus formation in a model of deep vein thrombosis","volume":"9","author":"Naber K","year":"2025","unstructured":"Naber K, Mauler M, Schanze N, et al.. Serotonin transporter deficiency, but not absence of platelet serotonin, impairs thrombus formation in a model of deep vein thrombosis. Res Pract Thromb Haemost. 2025, 9:102970. 10.1016\/j.rpth.2025.102970","journal-title":"Res Pract Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02331-0","article-title":"Serotonin: a platelet hormone modulating cardiovascular disease","volume":"52","author":"Rieder M","year":"2021","unstructured":"Rieder M, Gauchel N, Bode C, Duerschmied D. Serotonin: a platelet hormone modulating cardiovascular disease. J Thromb Thrombolysis. 2021, 52:42-7. 10.1007\/s11239-020-02331-0","journal-title":"J Thromb Thrombolysis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2007.10.004","article-title":"Selective serotonin reuptake inhibitors: measurement of effect on platelet function","volume":"151","author":"McCloskey DJ","year":"2008","unstructured":"McCloskey DJ, Postolache TT, Vittone BJ, Nghiem KL, Monsale JL, Wesley RA, Rick ME. Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Transl Res. 2008, 151:168-72. 10.1016\/j.trsl.2007.10.004","journal-title":"Transl Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7516.529","article-title":"SSRIs and gastrointestinal bleeding","volume":"331","author":"Paton C","year":"2005","unstructured":"Paton C, Ferrier IN. SSRIs and gastrointestinal bleeding. BMJ. 2005, 331:529-30. 10.1136\/bmj.331.7516.529","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1700952","article-title":"Clinically relevant drug interactions between newer antidepressants and oral anticoagulants","volume":"16","author":"Spina E","year":"2020","unstructured":"Spina E, Barbieri MA, Cicala G, Bruno A, de Leon J. Clinically relevant drug interactions between newer antidepressants and oral anticoagulants. Expert Opin Drug Metab Toxicol. 2020, 16:31-44. 10.1080\/17425255.2020.1700952","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/a-1957-6305","article-title":"Selective serotonin reuptake inhibitor use and risk of major bleeding during treatment with vitamin K antagonists: results of a cohort study","volume":"123","author":"Bakker S","year":"2023","unstructured":"Bakker S, Burggraaf JL, Kruip MJ, van der Meer FJ, Lijfering WM, van Rein N. Selective serotonin reuptake inhibitor use and risk of major bleeding during treatment with vitamin K antagonists: results of a cohort study. Thromb Haemost. 2023, 123:245-54. 10.1055\/a-1957-6305","journal-title":"Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.08.017","article-title":"Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies","volume":"118","author":"Laporte S","year":"2017","unstructured":"Laporte S, Chapelle C, Caillet P, et al.. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies. Pharmacol Res. 2017, 118:19-32. 10.1016\/j.phrs.2016.08.017","journal-title":"Pharmacol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.52965\/001c.39580","article-title":"Selective serotonin reuptake inhibitors and associated bleeding risks: a narrative and clinical review","volume":"10","author":"Edinoff AN","year":"2022","unstructured":"Edinoff AN, Raveendran K, Colon MA, et al.. Selective serotonin reuptake inhibitors and associated bleeding risks: a narrative and clinical review. Health Psychol Res. 2022, 10:39580. 10.52965\/001c.39580","journal-title":"Health Psychol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-018-2244-6","article-title":"Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects","volume":"92","author":"Baldo BA","year":"2018","unstructured":"Baldo BA. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Arch Toxicol. 2018, 92:2457-73. 10.1007\/s00204-018-2244-6","journal-title":"Arch Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/00912174251322356","article-title":"Tramadol and mental health: a systematic review of case reports describing psychological side-effects","volume":"61","author":"Gudla SS","year":"2026","unstructured":"Gudla SS, Bhumireddy SK, Vadaga AK. Tramadol and mental health: a systematic review of case reports describing psychological side-effects. Int J Psychiatry Med. 2026, 61:276-93. 10.1177\/00912174251322356","journal-title":"Int J Psychiatry Med"},{"key":"ref14","unstructured":"European Medicines Agency. Guideline on the summary of product characteristics (SPC) for veterinary medicinal products containing antimicrobial substances - Scientific guideline. (2023). Accessed. January 26, 2026: https:\/\/www.ema.europa.eu\/en\/guideline-summary-product-characteristics-spc-veterinary-medicinal-products-containing-a...."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10030420","article-title":"A standardized dataset of a spontaneous adverse event reporting system","volume":"10","author":"Khaleel MA","year":"2022","unstructured":"Khaleel MA, Khan AH, Ghadzi SM, Adnan AS, Abdallah QM. A standardized dataset of a spontaneous adverse event reporting system. Healthcare (Basel). 2022, 10:420. 10.3390\/healthcare10030420","journal-title":"Healthcare (Basel)"},{"key":"ref16","unstructured":"FDA Adverse Event Monitoring System (AEMS). (2026). Accessed. January 26, 2026: https:\/\/www.fda.gov\/safety\/fda-adverse-event-monitoring-system-aems."},{"key":"ref17","unstructured":"Medical Dictionary for Regulatory Activities (MedDRA). (2026). Accessed. January 26, 2026: https:\/\/www.meddra.org\/."},{"key":"ref18","unstructured":"MedDRA Web-Based Browser. (2015). Accessed. January 26, 2026: https:\/\/tools.meddra.org\/wbb\/?utm_medium=email&amp;utm_source=transaction."},{"key":"ref19","unstructured":"SAS\/STAT(R) 13.1 User's Guide. (2013). Accessed. January 26, 2026: https:\/\/support.sas.com\/documentation\/cdl\/en\/statug\/66859\/HTML\/default\/viewer.htm."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495738-pharmacovigilance-analysis-of-bleeding-events-associated-with-selective-serotonin-reuptake-inhibitors-ssris-using-the-us-food-and-drug-administration-adverse-event-reporting-system-faers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:15:38Z","timestamp":1780474538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495738-pharmacovigilance-analysis-of-bleeding-events-associated-with-selective-serotonin-reuptake-inhibitors-ssris-using-the-us-food-and-drug-administration-adverse-event-reporting-system-faers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.110163","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}